KALAVSKRYS• 6 Months (Normalized)
KALA vs KRYS (KALA BIO Inc. vs Krystal Biotech Inc.)
Showing Closing Date Range from Mar, 20 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
KALA Performance $0.52
-95.6%
KALA BIO Inc.
Normalized Baseline0.00%
KRYS Performance $336.67
+33.77%
Krystal Biotech Inc.
Normalized Baseline0.00%
Alpha Spread Margin KRYS LEADS
-129.37%
KRYS outperforming by 129.37%
KALAKRYS
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
KALA KRYS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | KALA Price | KALA Gain (%) | KRYS Price | KRYS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.52 | -95.60% | $336.67 | +33.77% | -129.37% |
| Sep 15, 2026 | $0.51 | -95.71% | $336.68 | +33.77% | -129.48% |
| Sep 14, 2026 | $0.54 | -95.43% | $340.03 | +35.10% | -130.53% |
| Sep 11, 2026 | $0.57 | -95.17% | $347.00 | +37.87% | -133.04% |
| Sep 10, 2026 | $0.56 | -95.25% | $345.55 | +37.30% | -132.55% |
| Sep 09, 2026 | $0.56 | -95.30% | $348.09 | +38.31% | -133.61% |
| Sep 08, 2026 | $0.54 | -95.46% | $351.26 | +39.57% | -135.03% |
| Sep 04, 2026 | $0.51 | -95.72% | $358.24 | +42.34% | -138.06% |
| Sep 03, 2026 | $0.56 | -95.27% | $371.47 | +47.60% | -142.87% |
| Sep 02, 2026 | $0.52 | -95.59% | $369.23 | +46.71% | -142.30% |
| Sep 01, 2026 | $0.53 | -95.51% | $363.84 | +44.56% | -140.07% |
| Aug 31, 2026 | $0.67 | -94.32% | $359.36 | +42.78% | -137.10% |
| Aug 28, 2026 | $0.69 | -94.18% | $351.46 | +39.65% | -133.83% |
| Aug 27, 2026 | $0.81 | -93.15% | $357.46 | +42.03% | -135.18% |
| Aug 26, 2026 | $0.82 | -93.11% | $359.76 | +42.94% | -136.05% |
Page 1 of 9